Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1106 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approval for Novartis Arcapta Neohaler

Arcapta Neohaler is indicated for the long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Arcapta 75

WHITEC chooses athenahealth as EHR vendor partner

WHITEC is tasked with providing outreach, education, and technical assistance to primary care practices wanting to implement and achieve meaningful use of certified EHRs. athenahealth will work with

Acura receives milestone payment from Pfizer

OXECTA, an immediate-release oxycodone HCl medicine, is indicated for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate.

AmerisourceBergen names new president, CEO

AmerisourceBergen’s service solutions range from pharmacy automation and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. Most recently, Collis worked as the president and chief operating officer of

Forest Labs rolls out MDD drug in US

The efficacy of VIIBRYD was established in two 8-week, placebo-controlled trials in adult patients with MDD. The mechanism of the antidepressant effect of VIIBRYD is thought to be